Biomarkers and surrogate end points in clinical trials of tuberculosis treatment

被引：5
|
作者：
Davies, Geraint Rhys
Phillips, Patrick P. J.
Nunn, Andrew J.
机构：
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England
[2] MRC, Clin Trials Unit, London, England
来源：
JOURNAL OF INFECTIOUS DISEASES | 2007年 / 196卷 / 04期
关键词：
D O I：
10.1086/519744
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页码：648 / 649
页数：2
相关论文
共 50 条
  • [41] Surrogate end points and their role in clinical trial
    Jaykaran
    INDIAN JOURNAL OF PHARMACOLOGY, 2009, 41 (01) : 54 - 54
  • [42] Biomarkers and surrogate end points-the challenge of statistical validation
    Buyse, Marc
    Sargent, Daniel J.
    Grothey, Axel
    Matheson, Alastair
    De Gramont, Aimery
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) : 309 - 317
  • [43] Biomarkers, Risk Factors, and Risk Clarifying the Controversy About Surrogate End Points and Clinical Outcomes
    Krumholz, Harlan M.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (05): : 457 - 459
  • [44] Surrogate End Points in Trials-SPIRIT and CONSORT Extensions
    Taylor, Rod S.
    Manyara, Anthony Muchai
    Ross, Joseph S.
    Ciani, Oriana
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [45] Small trials focusing on surrogate end points may be uninformative
    Hemila, Harri
    EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2007, 99 (06) : 707 - 708
  • [46] Small trials focusing on surrogate end points may be uninformative
    Harri Hemilä
    European Journal of Applied Physiology, 2007, 99 : 707 - 708
  • [47] Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
    Legro, RS
    Myers, E
    HUMAN REPRODUCTION, 2004, 19 (08) : 1697 - 1704
  • [48] Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials
    Boone, CW
    Bacus, JW
    Bacus, JV
    Steele, VE
    Kelloff, GJ
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1997, 216 (02): : 151 - 165
  • [49] A unified procedure for meta-analytic evaluation of surrogate end points in randomized clinical trials
    Dai, James Y.
    Hughes, James P.
    BIOSTATISTICS, 2012, 13 (04) : 609 - 624
  • [50] Clinical end points for stroke trials
    Zivin, JA
    ARCHIVES OF NEUROLOGY, 2000, 57 (08) : 1235 - 1235
12345